首页|基于网络药理学及分子对接探讨健脾益肺颗粒治疗慢性阻塞性肺疾病急性加重合并急性呼吸衰竭的作用机制

基于网络药理学及分子对接探讨健脾益肺颗粒治疗慢性阻塞性肺疾病急性加重合并急性呼吸衰竭的作用机制

扫码查看
目的:应用网络药理学探析健脾益肺颗粒治疗慢性阻塞性肺疾病急性加重合并急性呼吸衰竭的潜在作用机制,并通过分子对接技术加以验证,以期为后续基础及临床试验的开展提供方向和依据.方法:通过中药系统药理学数据库与分析平台(TCMSP)、SwissADME、PharmMapper数据库及文献筛选健脾益肺颗粒的活性成分并预测相应的作用靶点,利用GeneCards、DisGeNet、OMIM、DrugBank和NCBI数据库分别获得慢性阻塞性肺疾病急性加重、急性呼吸衰竭的疾病靶点,取药物与疾病的交集靶点.利用STING数据库及Cytoscape 3.8.2软件构建"中药-活性成分-靶点"与蛋白质-蛋白质相互作用网络.利用R软件进行交集靶点的基因本体论(GO)与京都基因与基因组百科全书(KEGG)富集分析.通过分子对接验证主要活性成分与核心靶点间的对接活性.结果:共筛选出健脾益肺颗粒111种活性成分和119个潜在作用靶点,与慢性阻塞性肺疾病急性加重及急性呼吸衰竭的交集靶点有32个.核心活性成分包括茯苓酸A、茯苓酸B、桑根酮B等;核心靶点包括白蛋白(Albumin,ALB)、表皮生长因子受体(Epidermal Growth Factor Receptor,EGFR)、酪氨酸蛋白激酶(Sarcoma,SRC)、胱天蛋白酶 3(Caspase 3,CASP3)、激酶插入区受体(Kinase Insert Domain Receptor,KDR)等;治疗 主要涉及血管内皮生长因子(Vascular Endothelial Growth Factor,VEGF)信号通路、酪氨酸激酶受体(Receptor Tyrosine Protein Kinase,ErbB)信号通路及促性腺激素释放激素(Gonadotropin-releasing Hormone,GnRH)信号通路.主要活性成分与核心靶点间有较高的结合活性.结论:健脾益肺颗粒可能通过多成分、多靶点在慢性阻塞性肺疾病急性加重合并急性呼吸衰竭的治疗中发挥抗炎、抗血管生成的辅助性治疗作用.
A study of mechanism of treating acute exacerbation of chronic obstructive pulmonary disease complicated with acute respiratory failure with the Jianpi Yifei granules based on network pharmacology and molecular docking
Objective:Aiming to provide direction and evidence for subsequent animal experiments and clinical trials,network pharmacology was used to probe the underlying mechanism of the Jianpi Yifei granules(健脾益肺颗粒)in the treatment of acute exacerbation of chronic obstructive pulmonary disease(AECOPD)complicated with acute respiratory failure(ARF),and molecular docking was carried out for preliminary validation.Methods:By TCMSP,SwissADME,PharmMapper databases,we collected the active ingredients of the Jianpi Yifei granules to predict the potential targets.The AECOPD and ARF-related disease targets were identified through GeneCards,DisGeNet,OMIM,DrugBank and NCBI databases,and intersected with the drug targets.The traditional Chinese medicine-active component-target network and the protein-protein interaction network were constructed by STRING database and Cytoscape 3.8.2 software.R software was adopted for GO and KEGG enrichment analyses of the drug and disease intersecting targets.Molecular docking was used to validate the binding activity between the core active ingredients and the key target proteins.Results:A total of 111 active ingredients and 119 potential targets were screened in the Jianpi Yifei granules,and there were 32 intersecting targets of the Jianpi Yifei granules and AECOPD complicated with ARF.After further filtering and analysis,the core active ingredients(poricoic acid A,poricoic acid B,and sanggenone B),the key targets(ALB,EGFR,SRC,CASP3,KDR),and the main involving signaling pathways(VEGF signaling pathway,ErbB signaling pathway,GnRH signaling pathway)were selected.The high binding activity between the core active ingredients and the key target proteins was confirmed by molecular docking.Conclusion:The Jianpi Yifei granules may play an adjuvant anti-inflammatory and anti-angiogenic role in the treatment of AECOPD combined with ARF through a multi-component,multi-target means.

The Jianpi Yifei granulesAcute exacerbation of chronic obstructive pulmonary diseaseAcute respiratory failureNetwork pharmacologyMolecular docking

蔡俊翔、黄楚栓

展开 >

广东省中医院,广东 广州,510120

广州中医药大学第一附属医院,广东 广州,510405

健脾益肺颗粒 慢性阻塞性肺疾病急性加重 急性呼吸衰竭 网络药理学 分子对接

广东省中医药局科研项目广东省中医院朝阳人才项目

20201166ZY2022YL01

2024

中医临床研究
中华中医药学会

中医临床研究

影响因子:0.839
ISSN:1674-7860
年,卷(期):2024.16(11)